BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20559098)

  • 1. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage.
    Ramakrishna R; Sekhar LN; Ramanathan D; Temkin N; Hallam D; Ghodke BV; Kim LJ
    Neurosurgery; 2010 Jul; 67(1):110-7; discussion 117. PubMed ID: 20559098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of microsurgical fenestration of the lamina terminalis on shunt-dependent hydrocephalus and vasospasm after aneurysmal subarachnoid hemorrhage.
    Komotar RJ; Hahn DK; Kim GH; Khandji J; Mocco J; Mayer SA; Connolly ES
    Neurosurgery; 2008 Jan; 62(1):123-32; discussion 132-4. PubMed ID: 18300899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid haemorrhage.
    Yang TC; Chang CH; Liu YT; Chen YL; Tu PH; Chen HC
    Eur Neurol; 2013; 69(5):296-303. PubMed ID: 23445755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage.
    Klimo P; Kestle JR; MacDonald JD; Schmidt RH
    J Neurosurg; 2004 Feb; 100(2):215-24. PubMed ID: 15086227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of clots in subarachnoid space could reduce the vasospasm after subarachnoid hemorrhage.
    de Aguiar PH; Barros I; Paiva BL; Simm RF
    Acta Neurochir Suppl; 2013; 115():91-3. PubMed ID: 22890652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
    Varelas PN; Rickert KL; Cusick J; Hacein-Bey L; Sinson G; Torbey M; Spanaki M; Gennarelli TA
    Neurosurgery; 2005 Feb; 56(2):205-13; discussion 205-13. PubMed ID: 15670368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular hemorrhage is associated with early hydrocephalus, symptomatic vasospasm, and poor outcome in aneurysmal subarachnoid hemorrhage.
    Wilson TJ; Stetler WR; Davis MC; Giles DA; Khan A; Chaudhary N; Gemmete JJ; Xi G; Thompson BG; Pandey AS
    J Neurol Surg A Cent Eur Neurosurg; 2015 Mar; 76(2):126-32. PubMed ID: 25545809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery.
    Andaluz N; Zuccarello M
    Neurosurgery; 2004 Nov; 55(5):1050-9. PubMed ID: 15509311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing subarachnoid fibrinolytic therapy for aneurysmal subarachnoid hemorrhage.
    Macdonald RL
    World Neurosurg; 2010 Jun; 73(6):622-3. PubMed ID: 20934139
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of cerebrospinal fluid drainage in patients with aneurysmal subarachnoid hemorrhage for prevention of symptomatic vasospasm and late hydrocephalus.
    Hirashima Y; Kurimoto M; Hayashi N; Umemura K; Hori E; Origasa H; Endo S
    Neurol Med Chir (Tokyo); 2005 Apr; 45(4):177-82; discussion 182-3. PubMed ID: 15849454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage.
    Yamada K; Yoshimura S; Enomoto Y; Yamakawa H; Iwama T
    Br J Neurosurg; 2008 Oct; 22(5):649-53. PubMed ID: 18686067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hydrocephalus and chronic hydrocephalus with the need of postoperative shunting after aneurysmal subarachnoid hemorrhage.
    Lin CL; Kwan AL; Howng SL
    Kaohsiung J Med Sci; 1999 Mar; 15(3):137-45. PubMed ID: 10224837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between shunt-dependent hydrocephalus after subarachnoid haemorrhage and duration of cerebrospinal fluid drainage.
    Ohwaki K; Yano E; Nakagomi T; Tamura A
    Br J Neurosurg; 2004 Apr; 18(2):130-4. PubMed ID: 15176553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.